Japan Biological Sample Handling market is expected to grow at CAGR of around 9.0% during the forecast period. The Japanese pharmaceutical industry is competitive in R&D capability. Japanese pharmaceutical companies have continued to increase their investments in R&D for the discovery and development of innovative new drugs every year, which represent more than 17% of total net sales. Japan contributes to improving the globe's medical care through the development of new pharmaceutical products. Japan is the third-largest country providing global "Top 100" selling pharmaceutical products
The other factors driving the market include growing government initiatives for R&D that is expected to fuel the growth of biological sample handling market in the country. The National Institute of Biomedical Innovation (NIBI) is a research branch of the National Institute of Health Sciences (NIHS). It is established to promote the development of medical devices and pharmaceuticals sector through the promotion and regulatory functions. Research supported by NIBI includes developing regulations and technologies for drug discovery such as Bioinformatics for drug discovery, Genome Medicine Database of Japan (GeMDBJ), Genomics and proteomics for pharmaceutical research and development, and Genomic toxicology for pharmaceutical toxicity prediction.
Japan has extensive specimen collections of diverse organisms which often have been managed by small-sized laboratories of academic or governmental institutes. The Japanese government has recently reorganized the management and funding scheme for biobanks as the government heavily emphasizes quality management of biological resources. In 2015, the Cabinet Office of Japan established Japan Agency for Medical Research and Development (AMED) as a “control tower” for medical research and development (R&D; Japan Agency for Medical Research and Development 2015).
Research Methodology
The market study of the Japan Biological Sample Handling market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report is intended for biological sample handling companies, storage companies, and other related companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Japan Biological Sample Handling Market by Storage Type
5.1.1. Cold Storage
5.1.2. Room Temperature Storage
5.2. Japan Biological Sample Handlings Market by Application
5.2.1. Drug Discovery
5.2.2. Forensic Investigation
5.2.3. DNA Extraction
5.2.4. Proteomics and Genomics Studies
5.2.5. Others
5.3. Japan Biological Sample Handlings Market by Ownership
5.3.1. Commercial
5.3.2. Academic/Research
6. Company Profiles
6.1. Abbott Laboratories
6.2. Becton, Dickinson And Co.
6.3. Brooks Automation, Inc.
6.4. Fisher BioServices
6.5. Sigma-Aldrich Co. LLC.
6.6. Technidata
1. JAPAN BIOLOGICAL SAMPLE HANDLING MARKET RESEARCH AND ANALYSIS BY STORAGE TYPE, 2018-2025 ($ MILLION)
2. JAPAN BIOLOGICAL SAMPLE HANDLING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
3. JAPAN BIOLOGICAL SAMPLE HANDLING MARKET RESEARCH AND ANALYSIS BY OWNERSHIP, 2018-2025 ($ MILLION)
1. JAPAN BIOLOGICAL SAMPLE HANDLING MARKET SHARE BY STORAGE TYPE, 2018 VS 2025 (%)
2. JAPAN BIOLOGICAL SAMPLE HANDLING MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)
3. JAPAN BIOLOGICAL SAMPLE HANDLING MARKET SHARE BY OWNERSHIP, 2018 VS 2025 (%)